Literature DB >> 1695912

Heterogeneity of serological responses in paucibacillary leprosy--differential responses to protein and carbohydrate antigens and correlation with clinical parameters.

P W Roche1, W J Britton, S S Failbus, H Ludwig, W J Theuvenet, R B Adiga.   

Abstract

We have examined the serological responses of 154 untreated paucibacillary (PB) leprosy patients to two carbohydrate and one protein antigens of Mycobacterium leprae. There was a heterogeneous response with 20% of PB patients having IgM anti-PGL-I antibodies and a similar proportion with IgG anti-LAM antibodies, while 33% had antibodies to the M. leprae-specific epitope on the 35-kDa protein. There was overlap in the responses such that 43% of the patients were seropositive in one of the two M. leprae-specific assays, while 49% were positive in any assay. There was a gradation in seropositivity with increasing extent of disease for each of the clinical parameters measured. Those with established disability at the time of presentation were more likely to be seropositive in each assay.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1695912

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN: 0148-916X


  4 in total

1.  Use of serum antibody and lysozyme levels for diagnosis of leprosy and tuberculosis.

Authors:  K A Near; M J Lefford
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

2.  Clinical usefulness of serological measurements obtained by antigen 60 in mycobacterial infections: development of a new concept.

Authors:  R Maes
Journal:  Klin Wochenschr       Date:  1991-10-02

3.  Specificity and function of immunogenic peptides from the 35-kilodalton protein of Mycobacterium leprae.

Authors:  R J Wilkinson; K A Wilkinson; S Jurcevic; A Hills; S Sinha; U Sengupta; D N Lockwood; K Katoch; D Altman; J Ivanyi
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

4.  The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy.

Authors:  G Kaplan; W J Britton; G E Hancock; W J Theuvenet; K A Smith; C K Job; P W Roche; A Molloy; R Burkhardt; J Barker
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.